FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET
Clinical trial NCT03726931 · COMPLETED
Trial details
- NCT number
- NCT03726931
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2023-01-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.